pre-IPO PHARMA

cero-therapeutics PRESS RELEASE ARCHIVE

Jun 5, 2023

CERo Therapeutics, Inc. and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Advancing the Development of Next Generation Engineered T Cell Therapeutics


May 2, 2022

CERo Therapeutics’ Multifunctional CER T Cells Synergize with Standard-of-Care Small Molecule Anti-Tumor Inhibitors Across Hematologic and Solid Tumor Models


Nov 12, 2021

CERo Therapeutics’ Novel Chimeric Engulfment Receptor T Cells Exhibit Multifunctional Properties and Enhanced Tumor Killing


Apr 15, 2021

CERo Therapeutics Expands Leadership Team with Experts in Cell Therapy Development


Google Analytics Alternative